(Q36273339)

13 August 2017

1 reference

title

Molecular targeting by homocysteine: a mechanism for vascular pathogenesis (English)

1 reference

13 August 2017

0 references

Donald W Jacobsen

1

1 reference

13 August 2017

Otilia Catanescu

series ordinal

2

1 reference

13 August 2017

Patricia M Dibello

series ordinal

3

1 reference

13 August 2017

John C Barbato

series ordinal

4

1 reference

13 August 2017

publication date

1 January 2005

1 reference

Clinical Chemistry and Laboratory Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

43

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

1076-1083

1 reference

Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Molecular basis of homocysteine toxicity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Homocysteine and redox signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

The matrix metalloproteinases and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Protein-Bound Homocyst(e)ine in Normal Subjects and in Patients with Homocystinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Upregulation of smooth muscle cell collagen production by homocysteine-insight into the pathogenesis of homocystinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Free and protein-bound homocysteine and cysteine in cystathionine beta-synthase deficiency: interrelations during short- and long-term changes in plasma concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Effect of hyperhomocysteinemia on protein C activation and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Methionine metabolism in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Folate, homocysteine, endothelial function and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

Facts and recommendations about total homocysteine determinations: an expert opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

A simple and reliable method of detecting variant transthyretins by multidimensional liquid chromatography coupled to electrospray ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.188

21 January 2018

Identifiers

DOI

10.1515/CCLM.2005.188

1 reference

13 August 2017

1 reference